<SEC-DOCUMENT>0000947871-20-000430.txt : 20200505
<SEC-HEADER>0000947871-20-000430.hdr.sgml : 20200505
<ACCEPTANCE-DATETIME>20200505171146
ACCESSION NUMBER:		0000947871-20-000430
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200505
DATE AS OF CHANGE:		20200505
EFFECTIVENESS DATE:		20200505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		20849964

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ss172987_defa14a.htm
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">UNITED STATES
</FONT><BR>
<FONT STYLE="font-size: 10pt">SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549 </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0pt; text-align: center">SCHEDULE 14A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0pt; text-align: center">Proxy Statement Pursuant to Section 14(a)
of the<BR>
Securities Exchange Act of 1934 (Amendment No. &nbsp; &nbsp; &nbsp; )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0pt">Filed by the Registrant &nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 12pt">&#9746;</FONT>&nbsp;&nbsp;
<BR>
Filed by a Party other than the Registrant &nbsp;&nbsp;<FONT STYLE="font-size: 12pt">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0">Check the appropriate box:</P>

<TABLE CELLSPACING="1" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 3%"><FONT STYLE="font-size: 12pt">&#9744;</FONT></TD>
    <TD STYLE="width: 97%"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 12pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&#9744;</TD>
    <TD><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&#9746;</TD>
    <TD><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&#9744;</TD>
    <TD><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant to Section 240.14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><BR>
</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">Quest Diagnostics Incorporated</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Name of Registrant as Specified In Its Charter) </FONT></TD></TR>
<TR>
    <TD STYLE="font: 6pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD>
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </FONT></TD></TR>
<TR>
    <TD STYLE="font: 6pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 12pt">&#9746;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 12pt">&#9744;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Title of each class of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Aggregate number of securities to which transaction applies: </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Proposed maximum aggregate value of transaction:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">5)</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Total fee paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 12pt">&#9744;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 12pt">&#9744;</FONT>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Amount previously paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form, Schedule or Registration Statement No.:</FONT>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">
</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Filing Party:</FONT>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: gray">

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 9.5pt TimesNewRomanPS-BoldMT; margin: 0; text-align: center"><B>ADDITIONAL INFORMATION REGARDING THE ANNUAL MEETING
OF STOCKHOLDERS</B></P>

<P STYLE="font: 9.5pt TimesNewRomanPS-BoldMT; margin: 0; text-align: center"><B>TO BE HELD ON TUESDAY, MAY 19, 2020</B></P>

<P STYLE="font: 9.5pt TimesNewRomanPSMT; margin: 0; text-align: center">-------------------------</P>

<P STYLE="font: 9.5pt TimesNewRomanPSMT; margin: 0">The following Notice of Change of Location relates to the notice of meeting
and proxy statement of Quest Diagnostics Incorporated. (the &#8220;Company&#8221;) dated April 8, 2020 (the &#8220;Proxy Statement&#8221;)
furnished to stockholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company
for use at the Annual Meeting of Stockholders to be held on Tuesday, May 19, 2020 (the &#8220;Annual Meeting&#8221;). This Supplement,
including a copy of a press release issued by the Company about the change of location, is being filed with the Securities and
Exchange Commission and made available to stockholders of the Company on or about May 5, 2020.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 9pt 0 7pt; text-align: center"><B>THE NOTICE SHOULD BE READ IN CONJUNCTION
WITH THE PROXY STATEMENT</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 9pt 0 7pt; text-align: center"><B>NOTICE OF CHANGE IN LOCATION
OF 2020 ANNUAL MEETING OF STOCKHOLDERS</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; width: 24%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>DATE:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; width: 1%">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify; width: 75%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">May 19, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>TIME:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">10:30 a.m.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>WHO MAY VOTE:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stockholders of record as of the close of business on March 20, 2020 are entitled to vote.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 3pt 0 9pt; text-align: justify">Dear Stockholders,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">After careful consideration, to protect the
health and safety of the Company&#8217;s stockholders and employees and due to the mandated limits on public gatherings as a result
of the public health threat caused by the COVID-19 pandemic, <B>NOTICE IS HEREBY GIVEN</B> that the Annual Meeting will be held
solely by remote communication through a live, online audio webcast on May 19, 2020 at 10:30 a.m. Eastern Time. Stockholders will
not be able to attend the Annual Meeting in person.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stockholders as of the close of business on
March 20, 2020 (the &#8220;Record Date&#8221;) will be able to participate in, vote at and ask questions during the Annual Meeting
through the webcast. The items of business are the same as set forth in the meeting notice previously mailed or made available.
Stockholders of record may register to attend by visiting <B>www.CESVote.com</B> no later than 24 hours before the Annual Meeting
and entering the 11-digit control number included on their Important Notice Regarding the Availability of Proxy Materials found
on their proxy card. Follow the directions to register for the Annual Meeting. Beneficial stockholders may register to attend the
Annual Meeting by securing a legal proxy from their bank, broker or other holder of record and emailing it to Corporate Election
Services at DGXregister@proxy-agent.com no later than 24 hours before the Annual Meeting, requesting to register to attend the
Annual Meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt">Stockholders that register to attend the Annual Meeting
will receive an e-mail prior to the meeting with a link and instructions for attending the Annual Meeting. On May 19, 2020, the
day of the Annual Meeting, stockholders registered to attend the Annual Meeting may log into the Annual Meeting platform at the
link included in their registration email beginning at 10:00 a.m. Eastern Time to participate. The Annual Meeting is expected to
begin promptly at 10:30 a.m. Eastern Time. To vote or submit a comment or question during the Annual Meeting, follow the instructions
available on the Annual Meeting platform.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Whether or not stockholders plan to join the Annual Meeting,
the Company urges stockholders to submit their proxies in advance of the Annual Meeting. </B>Stockholders should note that the
proxy card and voting instruction form included with previously distributed proxy materials may be used to vote shares in connection
with the Annual Meeting (they will not be updated to reflect that the Annual Meeting will be conducted solely by remote communication).
The stockholders list as of the Record Date will be available for inspection during normal business hours at the company&#8217;s
headquarters, 500 Plaza Drive, Secaucus, New Jersey 07094 for ten days prior to the Annual Meeting. In addition, stockholders registered
to attend the Annual Meeting will be able to inspect that list during the Annual Meeting at the online Annual Meeting platform
referred to above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B><BR>
Quest Diagnostics to Hold Virtual Annual Meeting of Stockholders</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">SECAUCUS, N.J., May 5, 2020 /PRNewswire/ --&nbsp;Quest Diagnostics
Incorporated (NYSE: DGX) today announced that its 2020 Annual Meeting of Stockholders (the &quot;Annual Meeting&quot;) will now
be held solely by remote communication through a live, online audio webcast. This decision was made as a result of the public health
threat caused by the COVID-19 pandemic, mandated limits on public gatherings and to protect the health and safety of the company's
stockholders and employees.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="https:||mma.prnewswire.com|media|200883|quest_diagnostics_incorporated_logo_logo.jpg?token=br5thbnr6EXk8U0Rrhk635RCe5rM212voX7CbgMbzr8y%2BdDb5mlX4FlF6xDVWutZ3jK7%2Bb24n5WtsqeU3ypgZQAMsJ3Zx7ufcJBzhCsR%2F0UHWaqY8XNl" STYLE="height: 190px; width: 400px"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">The Annual Meeting will be held online at 10:30 a.m. Eastern Time
on May 19, 2020. Stockholders will not be able to attend the Annual Meeting in person. Stockholders as of the close of business
on March 20, 2020 (the &quot;Record Date&quot;) will be able to participate in, vote at and ask questions during the Annual Meeting
through the webcast.&nbsp; The items of business are the same as set forth in the meeting notice previously mailed or made available.&nbsp;
Set forth below are instructions for stockholders to be admitted to, and participate in, the Annual Meeting.</P>

<UL STYLE="list-style-type: disc">

<LI STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt">Stockholders of record may register to attend by visiting
www.CESVote.com no later than 24 hours before the Annual Meeting and entering the 11-digit control number included on their Important
Notice Regarding the Availability of Proxy Materials found on their proxy card. Follow the directions to register for the Annual
Meeting.</LI>

<LI STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt">Beneficial stockholders may register to attend the Annual
Meeting by securing a legal proxy from their bank, broker or other holder of record and emailing it to Corporate Election Services
at <FONT STYLE="color: windowtext">DGXregister@proxy-agent.com</FONT>&nbsp;no later than 24 hours before the Annual Meeting, requesting
to register to attend the Annual Meeting.</LI>

<LI STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt">Stockholders that register to attend the Annual Meeting
will receive an e-mail prior to the meeting with a link and instructions for attending the Annual Meeting.</LI>

<LI STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt">On May 19, 2020, the day of the Annual Meeting, stockholders
registered to attend the Annual Meeting may log into the Annual Meeting platform at the link included in their registration email
beginning at 10:00 a.m. Eastern Time to participate. The Annual Meeting is expected to begin promptly at 10:30 a.m. Eastern Time.</LI>

<LI STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt">To vote or submit a comment or question during the Annual
Meeting, follow the instructions available on the Annual Meeting platform.</LI>

</UL>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Stockholders should note that the proxy card and voting instruction
form included with previously distributed proxy materials may be used to vote shares in connection with the Annual Meeting (they
will not be updated to reflect that the Annual Meeting will be conducted solely by remote communication).&nbsp; Whether or not
stockholders plan to join the Annual Meeting, the company urges stockholders to submit their proxies in advance of the Annual Meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">The stockholders list as of the Record Date will be available for
inspection during normal business hours at the company's headquarters, 500 Plaza Drive, Secaucus, New Jersey 07094 for ten days
prior to the Annual Meeting.&nbsp; In addition, stockholders registered to attend the Annual Meeting will be able to inspect that
list during the Annual Meeting at the online Annual Meeting platform referred to above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>About Quest Diagnostics</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Quest Diagnostics empowers people to take action to improve health
outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify
and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans
and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with
the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>About COVID-19 Testing by Quest Diagnostics</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Quest Diagnostics is at the forefront of response to the COVID-19
pandemic, working to broaden access to laboratory insights to help us all lead healthier lives. We provide both molecular diagnostic
and antibody serology tests to aiding the diagnosis of COVID-19 and immune response. Our COVID-19 test services are based on tests
that have received or are expected to receive FDA emergency use authorization and which also meet our high standards for quality.
We provide data on COVID-19 testing to various federal and state public health authorities, including the Centers for Disease Control
and Prevention, and participate in studies with government and private institutions, aiding COVID-19 public health response and
research. Through our team of dedicated phlebotomists, couriers, air fleet team, and laboratory professionals, Quest Diagnostics
won't stop until quality testing is broadly available to patients and communities across the United States.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">For more information about the latest developments with our COVID-19
testing, visit: newsroom.questdiagnostics.com/COVIDTestingUpdates</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">CONTACT: Shawn Bevec (Investors), 973-520-2900; Dennis Moynihan (Media),
973-520-2800</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[0(L4&AO=&]S:&]P(#,N,  X0DE-! 0
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M%A86%A86%A86%O_  !$( +X!D ,!(@ "$0$#$0'_Q  =  $  @(# 0$
M        !@@%!P$#! D"_\0 41   00! @,%! 8%!P<*!P   0 " P0%!A$'
M$B$($S%!42)A<8$4%3)2D:$)0F)R@B,D,SACL;)35G62HK.T%A<8)30U-W1V
MP4-SE*/"T>'_Q  : 0$  @,!                 @,!! 4&_\0 ,1$  @("
M 0,!!@0& P        $" P01(1(Q0043(C)187&AL='P%#-"@<'A%9'Q_]H
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M,S#-QYO49HVXBZ,=<J7J<=JE9ALP2CFCEAD#V/'J'#H0N]7&T$1$ 1$0!$1
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MBSG]1T<)5#I+&3MQUH_,ETC@W<_CNMSU"]=2J7?R<_U2S<54O)?3LS8]^-X
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MIEY&M$MACXFR&.4M]ETD9/*2/'<;]5LU3@TX[1;4TX+01$4RP(B( B(@"(B
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
